AU2010210535B2 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure - Google Patents

Methods and compositions for diagnosis and prognosis of renal injury and renal failure Download PDF

Info

Publication number
AU2010210535B2
AU2010210535B2 AU2010210535A AU2010210535A AU2010210535B2 AU 2010210535 B2 AU2010210535 B2 AU 2010210535B2 AU 2010210535 A AU2010210535 A AU 2010210535A AU 2010210535 A AU2010210535 A AU 2010210535A AU 2010210535 B2 AU2010210535 B2 AU 2010210535B2
Authority
AU
Australia
Prior art keywords
renal
measured concentration
subject
threshold
future
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010210535A
Other languages
English (en)
Other versions
AU2010210535A1 (en
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astute Medical Inc
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Priority to AU2010279249A priority Critical patent/AU2010279249B2/en
Publication of AU2010210535A1 publication Critical patent/AU2010210535A1/en
Application granted granted Critical
Publication of AU2010210535B2 publication Critical patent/AU2010210535B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2010210535A 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure Ceased AU2010210535B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2010279249A AU2010279249B2 (en) 2009-02-06 2010-08-06 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US15039309P 2009-02-06 2009-02-06
US15037209P 2009-02-06 2009-02-06
US15037409P 2009-02-06 2009-02-06
US61/150,393 2009-02-06
US61/150,372 2009-02-06
US61/150,374 2009-02-06
US16240209P 2009-03-23 2009-03-23
US16239609P 2009-03-23 2009-03-23
US61/162,402 2009-03-23
US61/162,396 2009-03-23
US16633309P 2009-04-03 2009-04-03
US61/166,333 2009-04-03
PCT/US2010/023292 WO2010091231A1 (en) 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2010279249A Division AU2010279249B2 (en) 2009-02-06 2010-08-06 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (2)

Publication Number Publication Date
AU2010210535A1 AU2010210535A1 (en) 2011-09-15
AU2010210535B2 true AU2010210535B2 (en) 2015-12-10

Family

ID=42542388

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010210535A Ceased AU2010210535B2 (en) 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Country Status (11)

Country Link
US (1) US20160123996A1 (enExample)
EP (1) EP2393937A4 (enExample)
JP (3) JP2012517592A (enExample)
CN (3) CN102369293B (enExample)
AU (1) AU2010210535B2 (enExample)
BR (1) BRPI1007917A2 (enExample)
CA (1) CA2751424A1 (enExample)
HK (1) HK1200218A1 (enExample)
MX (1) MX2011008323A (enExample)
NZ (1) NZ630621A (enExample)
WO (1) WO2010091231A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9057735B2 (en) 2008-08-29 2015-06-16 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2766228A1 (en) * 2009-07-02 2011-01-06 Mosaiques Diagnostics And Therapeutics Ag Process and markers for the diagnosis of acute renal failure
JP2013541005A (ja) * 2010-09-24 2013-11-07 アスチュート メディカル，インコーポレイテッド ヒアルロン酸を使用した腎損傷の評価のための方法ならびに組成物
EP2882767B1 (en) * 2012-08-11 2023-07-12 Astute Medical, Inc. Evaluating renal injury using hyaluronic acid
HK1219129A1 (zh) * 2013-01-29 2017-03-24 阿斯图特医药公司 用於肾损伤和肾衰竭的诊断及预後的方法和组合物
CN105917229B (zh) * 2013-12-03 2019-04-26 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
CL2015003047A1 (es) * 2015-10-15 2016-06-17 Univ Chile Método ex vivo para detectar precozmente injuria renal aguda en pacientes críticos, que comprende la mediciom en una muestra de tres proteinas como biomarcadores, factor de crecimiento fibroblástico 23, klotho y eritropoyetina
CN105466984B (zh) * 2016-01-14 2018-12-28 郑以山 用于肾脏非显性损伤的预警装置及其使用方法
WO2017130985A1 (ja) * 2016-01-29 2017-08-03 株式会社国際電気通信基礎技術研究所 腎機能の評価装置、腎疾患の合併症の発症の予測装置、およびリン摂取量推定装置
CN106845140A (zh) * 2017-03-01 2017-06-13 重庆工商大学 一种基于尿比重和尿量监测的肾衰竭预警方法及系统
MX2019014441A (es) * 2017-05-30 2020-02-10 Sphingotec Gmbh Un metodo in vitro para diagnosticar o monitorear la funcion renal o diagnosticar disfuncion renal.
CN109897108B (zh) * 2019-03-11 2021-04-02 上海恒赛生物科技有限公司 抗人内皮蛋白c受体的羊驼单域抗体及应用
EP3881862A1 (de) * 2020-03-18 2021-09-22 Pharis Biotec GmbH Polypeptid zur therapie von glomerulären nierenerkrankungen und analyse des verlaufes und prognose der abhängigen syndrome

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3569577B2 (ja) * 1995-09-04 2004-09-22 株式会社いかがく 腎・尿路系疾患の鑑別診断用キット
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
US6228360B1 (en) * 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
JP2003030100A (ja) * 2001-07-12 2003-01-31 Fuji Xerox Co Ltd インターネット情報提供システムおよびインターネット情報提供方法
ES2268961B1 (es) * 2005-03-17 2008-03-16 Proyecto De Biomedicina Cima, S.L. Nueva proteina epcr soluble de origen no proteolitico y su uso.
US7833732B2 (en) * 2005-07-21 2010-11-16 The John Hopkins University Acute renal injury
TW200726845A (en) * 2006-01-02 2007-07-16 Nat Defense Medical Ct Biomarker molecular of renal illness and detecting method for the same
US7662578B2 (en) * 2006-04-21 2010-02-16 Children's Hospital Medical Center Method and kit for the early detection of impaired renal status
US20080038269A1 (en) * 2006-05-25 2008-02-14 Mount Sinai Hospital Methods for detecting and treating kidney disease
GB0617429D0 (en) * 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2095107B1 (en) * 2006-11-14 2014-07-02 Alere San Diego, Inc. Methods for risk assignment
JP5661457B2 (ja) * 2007-06-06 2015-01-28 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． 腎疾患の予測診断

Also Published As

Publication number Publication date
HK1162617A1 (en) 2012-08-31
CN106546752A (zh) 2017-03-29
CN104111336A (zh) 2014-10-22
CN102369293A (zh) 2012-03-07
MX2011008323A (es) 2011-09-21
WO2010091231A1 (en) 2010-08-12
JP2016194526A (ja) 2016-11-17
AU2010210535A1 (en) 2011-09-15
BRPI1007917A2 (pt) 2019-09-24
CN102369293B (zh) 2014-05-28
HK1200218A1 (en) 2015-07-31
EP2393937A1 (en) 2011-12-14
JP2012517592A (ja) 2012-08-02
US20160123996A1 (en) 2016-05-05
CA2751424A1 (en) 2010-08-12
CN104111336B (zh) 2017-01-18
EP2393937A4 (en) 2012-08-08
JP2015096870A (ja) 2015-05-21
NZ630621A (en) 2016-03-31

Similar Documents

Publication Publication Date Title
AU2009313189B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009285550B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009316387B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009308375B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9057735B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9229010B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010210540B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and failure
AU2010210535B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010210537B2 (en) Diagnosis and prognosis of renal injury and renal failure
AU2010279249B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010286559A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2965153A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010315008A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010295512A1 (en) Methods and composition for diagnosis and prognosis of renal injury and renal failure
CA2865559A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2880793A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2865563A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2015202151A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2015200266A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2015203434A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2899658A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired